- Home
- LPTH vs TOVX Comparison
LPTH vs TOVX Comparison
Compare LPTH & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPTH | TOVX |
|---|---|---|
| Founded | 1985 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.1M | 7.3M |
| IPO Year | 1996 | 2006 |
Fundamental Metrics
Financial Performance| Metric | LPTH | TOVX |
|---|---|---|
| Price | $8.11 | $0.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $10.33 | N/A |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 11-11-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $43,860,530.00 | N/A |
| Revenue This Year | $69.65 | N/A |
| Revenue Next Year | $22.09 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 36.85 | N/A |
| 52 Week Low | $1.61 | $0.20 |
| 52 Week High | $10.69 | $2.08 |
Technical Indicators
Market Signals| Indicator | LPTH | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 42.02 |
| Support Level | $8.29 | $0.21 |
| Resistance Level | $9.34 | $0.24 |
| Average True Range (ATR) | 0.62 | 0.03 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 62.65 | 25.70 |
Price Performance
Historical ComparisonAbout LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.